Lineagen, Inc. Announces New Study Demonstrating Two-Fold Increase in Detection Rate of Validated Genetic Variants in Individuals with Autism Spectrum Disorders
1/15/2013 9:44:27 AM
More...
|
Lineagen, Inc. CEO Michael Paul to Present Series B Update and Accelerated Demand for Company's Genetic Testing and Counseling Services at 2011 Biotech Showcase
1/4/2011 8:46:16 AM
More...
|
Lineagen, Inc. Aims for $15M Series B
1/4/2011 7:27:14 AM
More...
|
Lineagen, Inc. to Showcase $15 Million Series 'B' Round at the 9th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/4/2010 12:06:44 PM
More...
|
Lineagen, Inc. Selected to Present at the 2010 Genetic Risk Factors for Autism: Translating Discoveries into Diagnostics Symposium in Toronto
9/2/2010 10:39:57 AM
More...
|